---
document_datetime: 2024-04-16 12:08:34
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/zoonotic-influenza-vaccine-seqirus-epar-all-authorised-presentations_en.pdf
document_name: zoonotic-influenza-vaccine-seqirus-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7830618
conversion_datetime: 2025-12-19 00:59:57.830688
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number    | (Invented) name                    | Strength   | Pharmaceutical Form      | Route of Administration   | Immediate Packaging        | Content (concentration)   | Pack size              |
|-------------------|------------------------------------|------------|--------------------------|---------------------------|----------------------------|---------------------------|------------------------|
| EU/1/23/1761 /001 | Zoonotic Influenza Vaccine Seqirus | --1        | Suspension for injection | Intramuscular use         | pre-filled syringe (glass) | 0.5 ml                    | 1 pre-filled syringe   |
| EU/1/23/1761 /002 | Zoonotic Influenza Vaccine Seqirus | --1        | Suspension for injection | Intramuscular use         | pre-filled syringe (glass) | 0.5 ml                    | 10 pre-filled syringes |

- --1 Influenza virus surface antigens (haemagglutinin and neuraminidase)* of strain: A/Astrakhan/3212/2020 (H5N8) - like strain (CBER-RG8A) (clade
- 2.3.4.4b) 7.5 micrograms** per 0.5 ml dose
* propagated in fertilised hens' eggs from healthy chicken flocks
- ** expressed in microgram haemagglutinin

Adjuvant MF59C.1 containing:

squalene

9.75 milligrams

polysorbate 80

1.175 milligrams

sorbitan trioleate

1.175 milligrams

sodium citrate

0.66 milligrams

citric acid

0.04 milligrams